Filing Details

Accession Number:
0000899243-19-003848
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-15 16:31:38
Reporting Period:
2019-02-13
Accepted Time:
2019-02-15 16:31:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1351288 Gw Pharmaceuticals Plc GWPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1754129 D. Justin Gover Sovereign House, Vision Park, Histon
Cambridge X0 CB24 9BZ
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2019-02-13 22,620 $12.50 370,445 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018.
  2. These ordinary shares are represented by American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer. The reporting person acquired these shares on December 20, 2018 in connection with an exercise of options that were due to expire on December 24, 2018.
  3. The price reported in Column 4 is price per ordinary share ($150.0 per ADS).